Ace News
Gland Pharma has reported results for second quarter ended September 30, 2024 (Q2FY25).
The company has reported 9.39% rise in its net profit at Rs 281.71 crore for the quarter ended September 30, 2024 as compared to Rs 257.53 crore for the same quarter in the previous year. Total income of the company increased by 6.56% at Rs 1,120.79 crore for Q2FY25 as compared to Rs 1,051.78 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 15.74% fall in net profit at Rs 163.53 crore for Q2FY25 as compared to Rs 194.08 crore for the same quarter in the previous year. However, total income of the company increased by 2.73% at Rs 1,465.49 crore for Q2FY25 as compared to Rs 1,426.58 crore for the corresponding quarter previous year.